The financial markets are not a forgiving place when it comes to uncertainty. Yet here we are, digesting the latest health bulletin from the Trump camp, which arrives with all the transparency of a hedge fund’s quarterly report. Dr. Sean Conley, the President’s physician, has declared Donald Trump in “excellent health” following a routine check-up at Walter Reed. But before the bond markets yawn and move on, the UK’s General Medical Council has waded in, branding the entire exercise a “PR stunt” designed to shore up confidence in a volatile asset: the President himself.
Let us calibrate our expectations. The White House medical summary is a carefully curated document, as selective as a leveraged buyout prospectus. It notes Trump’s perfect scores on cognitive tests, his stable heart, and his 24-point drop in LDL cholesterol since 2019. What it does not mention is the President’s gym avoidance (he favours golf carts over treadmills) or the fact that he carries the financial weight of a man whose diet is heavy on fast food. The GMC, normally the staid guardian of medical professionalism, has called the process “devoid of independent rigour” and little more than “a public relations exercise” to reassure markets spooked by his age and lifestyle.
This matters because presidential health is a macroeconomic variable. At 74, Trump is the oldest man ever to be elected as a first-term president. A health scare could trigger capital flight, especially if it coincides with a trade war or a surge in gilt yields. The GMC’s criticism amplifies that risk. Investors are already jittery: the US dollar index has been oscillating around 93, a level that suggests the market is pricing in a higher probability of a sudden political vacuum. The White House’s response, predictably, is to double down on the good news. Press secretary Kayleigh McEnany called the report “the gold standard of transparency.” But as any auditor will tell you, gold standards require independent verification.
Let us examine the numbers. Trump’s BMI of 30.5 puts him in the ‘obese’ category, a fact the report glosses over. His resting heart rate is 70, normal, but his stress test results are not publicly available. The GMC’s critique centres on the lack of peer review and the use of White House physicians who are, by their very appointment, partisan. In the City, this would be like a CEO commissioning his own health report and expecting shareholders to take it at face value. It doesn’t pass the sniff test.
The implications for the fiscal outlook are subtle but real. A healthy president is a green light for his agenda: tax cuts, deregulation, and a federal spending spree that has already pushed the national debt above £22 trillion. An unhealthy one invites a chaotic succession, with Vice President Pence’s more fiscally conservative stance potentially unsettling the expansionary bet. The GMC’s intervention, while limited to a statement, has already caused a ripple. UK gilts barely moved, but the 10-year US Treasury yield ticked up by 2 basis points, a small but telling sign that traders are adding a health risk premium.
My cynical view is that no amount of White House spin can replace an independent medical audit. The President’s health is a market variable, like oil inventories or central bank minutes. Attempts to manage it through press releases are like trying to control inflation with wishful thinking. Until we get a full, unredacted report from a non-partisan body, the ‘excellent health’ claim should be treated as a bullish signal from a biased source. For now, the market is giving it the benefit of the doubt. But on my desk, the red flags are waving.
Capital always finds the exit. The GMC has handed it a map.
